Correspondence
Letter to the Editor
Serum Cystatin C May Diagnose Rather Than Predict Acute Kidney Injury

https://doi.org/10.1053/j.ajkd.2011.07.028Get rights and content

Section snippets

Acknowledgements

Financial Disclosure: Drs Haase and Bellomo have received lecture fees from Abbott Diagnostics and Biosite/Alere Inc. Both companies are involved in the development of NGAL assays to be applied in clinical practice.

References (6)

There are more references available in the full text version of this article.

Cited by (0)

View full text